Analysis for Dyne Therapeutics, Inc. (DYN)

Add DYN to watchlist(s)

You Should Create a Watchlist In The First Place.

Price Over Time

Profile

Company Name

Dyne Therapeutics, Inc.

Symbol

DYN

Currency

USD

Exchange

Nasdaq

Head Quarter

United States, Waltham

Sector

Healthcare

Industry

Biotechnology

Website

https://www.dyne-tx.com

ISIN

US26818M1080

CIK

1818794

CUSIP

26818M108

UEI

-

LEI

-

Business Description

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..